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Background: To compare the effects of laparoscopic-assisted gastrectomy (LAG) and open gastrectomy (OG) on
serum interleukin-6 (IL-6) levels in gastric cancer (GC) patients from Asia.
Methods: The following scientific literature databases were searched for relevant clinical studies: PubMed, EBSCO, Ovid,
Wiley, Web of Science, Cochrane library, EMBASE, WANFANG and VIP databases. The studies retrieved from database
searches were screened based on stringent inclusion and exclusion criteria to select high quality cohort studies for the
present meta-analysis. The data extracted from final selected studies were analyzed using STATA 12.0 software.
Results: A total of 54 studies were initially retrieved from database searches, and 11 clinical cohort studies were
eventually enrolled in this meta-analysis. The 11 selected studies contained a combined total of 767 GC patients
(427 patients in LAG group and 340 patients in OG group). Meta-analysis results demonstrated that postoperative
serum IL-6 levels in GC patients in LAG group was significantly lower than the OG group (SMD = −2.16, 95%
CI = −3.19 ~ −1.14, P < 0.001). The difference in serum IL-6 levels between the preoperative and postoperative
GC patients was significantly lower in the LAG group compared to the difference found in the OG group (SMD = −3.44,
95% CI = −4.87 ~ −2.01, P < 0.001). Subgroup analysis based on country showed that, in both Chinese and Japanese GC
patients, the postoperative increase in serum IL-6 levels in LAG group were significantly lower than the increase
observed in the OG group (all P < 0.05). In Korean GC patients, the postoperative increase in serum IL-6 levels was
not significantly different between the LAG group and OG group (all P > 0.05).
Conclusion: Our results provide strong evidence that LAG is associated with significantly lower serum IL-6 levels,
compared to OG. Thus, LAG carries markedly lower risk of adverse inflammatory reactions in GC patients among
Asian population.
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Gastric cancer (GC) is a cancer originating from the
tissue lining of the stomach. Despite a worldwide de-
crease in the incidence of GC in the past 40 years, GC
remains the fourth most common cancer and the sec-
ond major cause of cancer-related death globally[1,2].* Correspondence: sunlibo0722@163.com
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unless otherwise stated.GC is uncommon in the United States and Europe, but
is much more common in China and Japan, and other
Asian countries. Apart from Asia, GC also has a higher
incidence in South America [3].Surgical resection by
gastrectomy is the only option for GC treatment that is
sufficient to cure early-stage gastric cancer patients,
and significantly enhance patient survival in more ad-
vanced GC, when combined with radiation therapy and
chemotherapy. Among the options for gastrectomy,
open gastrectomy (OG) has traditionally been widelyis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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volving the use of laparoscopic surgery and its related
equipment, was developed as a minimally invasive ap-
proach and has also been in use since its first descrip-
tion in 1999 for treatment of GC [5,6]. However, LAG
has limited field of vision compared to OG and the choice
between OG and LAG is much debated in literature, with
no firm conclusions. Notably, a recent study found that
interleukin-6 (IL-6) is a major factor in peritoneal immune
response after surgery in GC patients, and surgical options
for GC will need to be re-evaluated in light of the poten-
tially adverse influence of inflammatory responses on
therapy safety and effectiveness [7].
IL-6 is a 26 kDa protein initially described as a B cell
activating factor produced by T cells, and is mapped to
7p15-p21 chromosome [8]. As a dual-property cytokine
with pro-inflammatory and anti-inflammatory roles, IL-6
is prominently involved in inflammatory processes dur-
ing host immune defense response and stimulates
growth and proliferation of a variety of immune cell
types, and IL-6 is regarded as a key regulator in human
immune regulation and inflammatory reaction [9]. In-
flammatory reaction is activated by the surgical proce-
dures, and there is an association between the extent of
the surgical trauma and the inflammatory response [10].
IL-6 serum levels are positively associated with the se-
verity and the extent of postoperative inflammation, and
IL-6 is regarded as a reliable indicator of inflammatory
reaction for comparing the efficacies of OG and LAG
for treatment of GC [7]. LAG is associated with lower
serum IL-6 levels compared to OG [11] and the surgery-
induced increase in serum IL-6 levels are significantly
lower for LAG, compared to the levels induced following
OG [12,13]. Apart from the lower serum IL-6 levels,
LAG offers the advantages of less blood loss, reduced
postoperative complications, shorter hospital stays and
accelerated recovery [14]. Current studies have shown
that LAG involves less surgical trauma compared with
OG, and serum IL-6 levels is lower in the laparoscopic
operation [15,16]. However, other studies show contrast-
ing results [17,18]. To address this issue, we conducted
the present meta-analysis to compare the effect of LAG
and OG on serum IL-6 levels in Asian GC patients.
Methods
A systematic review of meta-analysis was conducted and
the results were described according to the PRISMA
statement [19].
Literature search
To retrieve relevant literature comparing the effects of
LAG and OG on serum IL-6 levels in GC patients, we
comprehensively searched the following electronic data-
bases: PubMed, EBSCO, Ovid, Wiley, Web of Science,Cochrane library, EMBASE, WANFANG and VIP data-
bases (last updated search in December 2014), without
language restrictions. Keywords used for electronic da-
tabases search were: stomach neoplasms, Interleukin-6,
IL-6, laparoscope gastrectomy and open gastrectomy in
combination with the Boolean operators AND, OR and
NOT. We also manually searched related bibliographies
for studies that were missed in the initial electronic
search.
Inclusion and exclusion criteria
In this meta-analysis, studies were selected if they met
the following inclusion criteria: (1) study design: clinical
cohort trial; (2) study issue: the effects of LAG and OG
on serum IL-6 levels in GC patients; (3) study subject:
GC patients verified by endoscopy and biopsy and
patients treated with LAG or OG; (4) detection method
for IL-6 levels: enzyme-linked immune sorbent assay
(ELISA); (5) detection times for IL-6 levels: 24 h before
operation and 24 h after operation; (6) trials provided
sufficient data required for our study, such as preopera-
tive IL-6 levels and postoperative IL-6 levels; (7) studies
were either Chinese or English. In cases of overlap re-
ports, we included only the latest results. Studies were
excluded if they failed to meet the inclusion criteria.
Study with patients who had a history of previous
treatment of GC, chemotherapy or radiation was also
excluded.
Data extraction and quality assessment
All data from eligible trials were extracted by two inves-
tigators independently using a standard form, and the
following information was collected: first author, publi-
cation year, country, ethnicity, language, disease, detec-
tion method, age, gender and sample number. Critical
appraisal skill program (CASP) score criteria of Oxford
Center for Evidence-based Medicine was employed for
methodological assessment of quality of the included co-
hort studies [20]. Each included study was scored on 12
aspects: (1) whether the study address a clearly focused
issue (CASP01); (2) whether the cohort were chosen in
an acceptable way (CASP02); (3) whether the exposure
precisely measured to reduce bias (CASP03); (4) whether
the outcome precisely measured to reduce bias
(CASP04); (5) whether the authors identified all signifi-
cant confounding factors; whether they considered con-
founding factors in the design or analysis (CASP05); (6)
whether the follow up of subjects was complete; whether
the follow up of subjects was long enough (CASP06); (7)
whether the result of this study in complete (CASP07);
(8) whether the result was accurate (CASP08); (9)
whether the result of the study in believable (CASP09);
(10) whether the result could be applied to local popula-
tion (CASP10); (11) whether the result fit with other
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provided implication for practice (CASP12). The quality
evaluation of included studies was performed by two
investigators. Any disagreement in study selection or
quality assessment was resolved by further discussion.
Statistical analysis
Statistical analyses were carried out with the STATA
statistical software (Version 12.0, Stata Corporation,
College Station, TX, USA). To compare the effects of
LAG and OG on serum IL-6 levels in GC patients, stan-
dardized mean difference (SMD) with 95% confidence
interval (95%CI) was analyzed. Z test was applied to
evaluate the significance of overall effect size (SMDs)
[21]. Heterogeneity among the studies were evaluated by
Cochran’s Q-statistic (P < 0.05 was considered as evident
heterogeneity) and I2 test which is the percentage of
total variation across studies ranging from 0 to 100%
[22,23]. A random effects model was applied if there was
significant heterogeneity (P < 0.05 or I2 > 50%), otherwise
a fixed effects model was employed [24]. Univariate and
multivariate meta-regression analysis was utilized to
identify potential sources of heterogeneity, and furtherFigure 1 Flow chart shows the detailed study inclusion and exclusion procedconfirmed by Monte Carlo method [25,26]. Additionally,
we applied a sensitivity analysis to evaluate whether
one single study had the weight to impact the overall
estimate. Further, the existence of publication bias was
detected by funnel plot and Egger’s linear regression
test (P < 0.05 was considered significant) [22,27].
Results
The baseline characteristics of included studies
A total of 54 studies were initially retrieved through
electronic database search and manual search. Our se-
lection criteria excluded duplicates (n = 2), letters, re-
views or meta-analyses (n = 2), non-human studies (n =
4), and studies not related to research topics (n = 8). The
remaining studies (n = 38) were reviewed carefully to
examine the full text for data integrity. Subsequently, add-
itional studies were excluded because they lacked suffi-
cient data (n = 25) or did not contain high quality data
(n = 2). Eventually, 11 cohort studies [5,17,18,28-35],
published between 1998 and 2014, were included in this
meta-analysis. The 11 clinical cohort studies contained
a combined total of 767 GC patients (427 patients in
LAG group and 340 patients in OG group). Within theures. Eleven clinical cohort studies were included in this meta-analysis.
Table 1 Baseline characteristics of the enrolled 11 clinical cohort studies
First author Year Country Sample Size Gender (M/F) Age (years) Method
LAG OG LAG OG LAG OG
Choi YB [17] 2002 Japan 10 10 7/3 9/1 58.7 (33 ~ 80) 60.4 (25 ~ 78) ELISA
Hayashi H [18] 2005 Japan 14 14 9/5 13/1 56 (47 ~ 70) 62 (49 ~ 75) ELISA
Jung IK [34] 2008 Korea 10 10 4/6 9/1 54.8 ± 16.1 62.9 ± 6.6 ELISA
Shao WX [30] 2009 China 47 47 31/16 30/17 57.7 (26 ~ 77) 57.0 (28 ~ 76) ELISA
Chen XZ [5] 2011 China 15 15 12/3 12/3 52.3 ± 12.2 54.3 ± 12.3 ELISA
Park JY [35] 2012 Korea 120 30 65/55 18/12 55 (45 ~ 64) 50 (45 ~ 54) ELISA
Huang X [29] 2012 China 30 30 21/9 23/7 56 58 ELISA
Zhou B [33] 2012 China 45 45 24/21 25/20 51.8 ± 10.6 50.1 ± 11.4 ELISA
Chen Z [28] 2013 China 36 36 19/17 21/15 52.6 ± 4.2 53.2 ± 4.8 ELISA
Xia YB [31] 2013 China 55 59 33/22 39/20 54.0 ± 3.2 52.7 ± 1.8 ELISA
Yin ZW [32] 2014 China 45 44 29/16 33/11 55.9 ± 8.5 56.1 ± 7.9 ELISA
M male; F female; ELISA enzyme-linked immune sorbent assay; LAG laparoscopic-assisted gastrectomy; OG open gastrectomy.
Shu et al. BMC Gastroenterology  (2015) 15:52 Page 4 of 1111 studies, 7 trials were conducted in China, 2 trials
were performed in Japan and 2 trials were performed in
South Korea. Figure 1 shows the flow chart of the study
selection process. Demographic information and base-
line characteristics of the enrolled studies and CASP
score are showed in Table 1 and Figure 2, respectively.
Comparison of postoperative serum IL-6 levels in LAG
and OG groups
A random effects model was applied for existence of
heterogeneity among the included studies (I2 = 96.4%,
P < 0.001). The result of this meta-analysis demonstratedFigure 2 The critical appraisal skill program (CASP) score for assessing thethat postoperative serum IL-6 level of GC patients in
LAG group was significantly lower than in the OG
group (SMD = −2.16, 95% CI = −3.19 ~ −1.14, P < 0.001)
(Figure 3A). Subgroup analysis based on country showed
that, in Chinese and Japanese GC patients, postopera-
tive serum IL-6 levels in LAG group were significantly
lower than OG group (Japanese: SMD = −1.19, 95%
CI = −1.81 ~ −0.57, P < 0.001; Chinese: SMD = −2.78,
95% CI = −4.21 −1.36, P < 0.001). In Korean GC pa-
tients, however, postoperative serum IL-6 levels in
LAG group and OG group showed no statistical differ-
ences (SMD = −0.85, 95% CI = −2.02 0.33, P = 0.157).methodological quality for the eleven enrolled clinical cohort studies.
Figure 3 Forest plots. (A) Comparison of postoperative IL-6 levels (LAG group VS. OG group). (B) Comparison of postoperative increased IL-6
levels (LAG group VS. OG group).
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vealed that, whether the sample size was less than 50
or more than 50, the postoperative serum IL-6 levels in
LAG group were significantly lower than the IL-6 levels in
the OG group (sample size < 50: SMD = −0.97,
95% CI = −1.63 ~ −0.32, P = 0.003; sample size > 50:
SMD = −2.80, 95% CI = −4.22 ~ −1.38, P < 0.001)
(Figure 4A-B). Univariate meta-regression analysis re-
vealed that publication year, sample size, country and
language were not the potential sources of heterogen-
eity (all P > 0.05). Language is a possible source of het-
erogeneity, while publication year, sample size and
country were not the potential sources of heterogen-
eity. (Figure 5A-D). Multivariate meta-regression ana-
lysis further confirmed that publication year, sample
size, country and language were not the potential
sources of heterogeneity (Table 2).Comparison of the differences between preoperative and
postoperative serum IL-6 levels in LAG and OG groups
After Cochran’s Q-statistic and I2 tests, a random effects
model was used due to the existence of heterogeneity
among the included studies (I2 = 97.5%, P < 0.001). The re-
sult of this meta-analysis revealed that in LAG group, the
difference between preoperative and postoperative serum
IL-6 level in GC patients was lower than the difference seen
in the OG group (SMD = −3.44, 95% CI = −4.87 ~ −2.01,
P < 0.001) (Figure 3B). Subgroup analysis based on
country showed that, in Chinese and Japanese GC pa-
tients, the increase in postoperative serum IL-6 levels
in LAG group were significantly lower than the postop-
erative increases found in the OG group (Japanese:
SMD= −2.03, 95% CI = −2.74 ~ −1.32, P < 0.001; Chinese:
SMD = −4.27, 95% CI = −6.40 ~ −2.14, P < 0.001). In
Korean GC patients, postoperative increased serum
Figure 4 Forest plots of subgroup analyses based on country and sample size. (A) Subgroup analyses based on country for the comparison of
postoperative IL-6 levels (LAG group VS. OG group). (B) Subgroup analyses based on sample size for the comparison of postoperative IL-6 levels
(LAG group VS. OG group). (C) Subgroup analyses based on country for the comparison of postoperative increased IL-6 levels (LAG group VS. OG
group). (D) Subgroup analyses based on sample size for the comparison of postoperative increased IL-6 levels (LAG group VS. OG group).
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ferent (SMD = −1.91, 95% CI = −4.61 ~ 0.79, P = 0.166).
Additional subgroup analysis based on sample size re-
vealed that, whether studies contained sample size < 50
or > 50, the increases in postoperative serum IL-6 levels
in LAG group were lower than the post-operative increases
found in the OG group (sample size < 50: SMD= −1.81,
95% CI = −3.26 ~ −0.36, P = 0.015; sample size > 50:
SMD = −4.35, 95% CI = −6.34 ~ −2.35, P < 0.001)
(Figure 4C-D). Univariate meta-regression analysis re-
vealed that publication year, sample size, country and
language were not the potential sources of heterogen-
eity (all P > 0.05) (Figure 5E-H). Multivariate meta-
regression analysis further confirmed that publicationyear, sample size, country and language were not the
potential sources of heterogeneity (Table 3).
Sensitivity analysis and publication bias
The result of sensitivity analysis showed that any single
study selected in this meta-analysis had no significant ef-
fect on the pooled SMDs (Figure 6A-B). The symmetric
funnel plots for comparison of postoperative serum IL-6
levels of GC patients between LAG group and OG
group suggested no publication bias in the enrolled stud-
ies (Figure 6C). The Egger linear regression analysis fur-
ther confirmed the evidence of no publication bias (P =
0.095). The funnel plots for comparison of postoperative
increased serum IL-6 levels of GC patients between
Figure 5 (See legend on next page.)
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Figure 5 Univariate meta-regression analysis. (A) Univariate meta-regression analysis on Year for the comparison of postoperative serum IL-6
levels (LAG group VS. OG group). (B) Univariate meta-regression analysis on Sample size for the comparison of postoperative serum IL-6 levels
(LAG group VS. OG group). (C) Univariate meta-regression analysis on Country for the comparison of postoperative serum IL-6 levels (LAG group
VS. OG group). (D) Univariate meta-regression analysis on Language for the comparison of postoperative serum IL-6 levels (LAG group VS. OG
group). (E) Univariate meta-regression analysis on Year for the comparison of postoperative increased serum IL-6 levels (LAG group VS. OG group).
(F) Univariate meta-regression analysis on Sample size for the comparison of postoperative increased serum IL-6 levels (LAG group VS. OG group).
(G) Univariate meta-regression analysis on Country for the comparison of postoperative increased serum IL-6 levels (LAG group VS. OG group).
(H) Univariate meta-regression analysis on Language for the comparison of postoperative increased serum IL-6 levels (LAG group VS. OG group).
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suggesting existence of publication bias (Figure 6D). The
presence of bias may have resulted from the use of pre-
operative data for the analysis of postoperative increase
of IL-6. The Egger linear regression analysis further
confirmed the presence of publication bias (P = 0.009).
Discussion
In order to examine the change in serum IL-6 level after
LAG and OG treatment in GC patients, a systematic
meta-analysis was performed. The main result of this
meta-analysis showed that postoperative serum IL-6
level was significantly lower in LAG group compared to
OG group. The increase in postoperative serum IL-6
levels of GC patients in the LAG group was also signifi-
cantly lower than postoperative increases found in the
OG group. IL-6 is secreted at local sites and released
into the blood circulation when homeostatic perturb-
ation occur such as endotoxemia, trauma, endotoxic
lung, and acute infections [36]. IL-6 mediates inflamma-
tory process by stimulating B cell activation, B cell dif-
ferentiation, differentiation of T cell and macrophages
and NK cell activation [37]. Additionally, IL-6 has a
broader biological function as an adipokine and a myo-
kine for muscle contractions, and as a neuropeptide
[38]. Relevant to cancers, IL-6 activates STAT3 signaling
pathways and high levels of IL-6 is associated with poor
prognosis in a variety of cancers such as prostate cancer,
bladder cancer, ovarian cancer, colorectal cancer and GC
[39,40]. IL-6 is also an important mediator of acute-




Year 0.293 0.404 0
Sample Size −0.018 0.020 −
Country −0.500 1.902 −
Language −2.399 1.856 −
SE Standard Error; LL Lower Limit; UL Upper Limit.patients correlate with the severity of surgical trauma,
loss of blood, surgical duration and tissue damage
[41,42]. Compared with OG, surgical stress of LAG is
lower and results in reduced inflammation [43,44]. Be-
sides, with reduced manipulation response, LAG has ad-
vantages in less blood loss and pain during the surgery,
earlier wound recovery, shorter hospital stays and
quicker convalescence [14,45].From the above analysis,
although IL-6 serum levels increased after both OG or
LAG treatments, significantly lower increases were
found in LAG group, indicating that LAG treatment
shows a better surgical outcome, compared to OG, with
a higher safety profile and reduced inflammatory re-
sponses, which are significant advantages that influence
the overall patient survival. Consistent our analysis,
Adachi et al., also found that the serum IL-6 level
showed a marked increase after OG or LAG treatment,
but serum IL-6 level decreased more rapidly in LAG
group on day 3, suggesting an additional advantage of
LAG over OG [15].
The influence of other factors, such as country and sam-
ple size, on the relationship between IL-6 level and OG or
LAG treatments was examined by subgroup analyses. A
subgroup analysis based on country revealed that in both
Chinese and Japanese GC patients, the postoperative
serum IL-6 levels were significantly lower in LAG group
compared to the IL-6 levels found in the postoperative
OG group. In Korean GC patients, however, the postoper-
ative serum IL-6 levels in LAG group and OG group
showed no statistical differences. The possible explanation
may be the influence of different life styles on relativelyheterogeneity
P(Adjusted) 95% CI
LL UL
.73 0.832 −0.695 1.281
0.91 0.717 −0.104 0.031
0.26 0.998 −7.725 4.155
1.29 0.503 −11.084 2.141
Table 3 Meta-regression analyses of potential source of heterogeneity
Heterogeneity
factors




Year 0.347 0.649 0.53 0.938 −1.242 1.935
Sample Size −0.024 0.033 −0.72 0.853 −0.104 0.056
Country −0.253 3.054 −0.08 1.000 −7.725 7.219
Language −3.798 2.978 −1.28 0.530 −11.084 3.488
SE Standard Error; LL Lower Limit; UL Upper Limit.
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level in LAG treatment, compared with OG treatment,
was confirmed in our analysis, which is consistent with
previous studies, suggesting that the choice of gastrectomy
procedures should be carefully considered based on indi-
vidual patient’s pathology and co-morbidity, to deriveFigure 6 Sensitivity analysis and publication bias assessment. (A) Sensitivity a
VS. OG group). (B) Sensitivity analysis for the comparison of postoperative inc
assessment for the comparison of postoperative serum IL-6 levels (LAG group
postoperative increased serum IL-6 levels (LAG group VS. OG group).maximal outcomes for GC patients. In this respect, our
results provide evidence that LAG is a better option for
GC treatment.
There were several limitations in our present meta-
analysis. First, the relatively small number of studies and
the small sample size may have an influenced ournalysis for the comparison of postoperative serum IL-6 levels (LAG group
reased serum IL-6 levels (LAG group VS. OG group). (C) Publication bias
VS. OG group). (D) Publication bias assessment for the comparison of
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each were reported in the study of Jung IK et al., and
other studies also reported relatively small sample size.
Second, the serum levels of IL-6 is associated with the
degree of surgery-associated stress, nevertheless, other
cytokines and hormones, such as TNF, IFN-c and cate-
cholamines, are also elevated during surgical stress and
significantly influence the overall inflammatory response,
and is not just limited to IL-6. However, in this current
meta-analysis, we did analyze the data related to the
levels of other cytokines. Third, Figure 6C shows sym-
metric shape for the comparison on postoperative serum
IL-6 levels of GC patients between LAG group and OG
group, while Figure 6D shows asymmetric shape for the
postoperative increased serum IL-6 levels of GC patients
between LAG group and OG group. A contradiction
exists in this results and the possible explanation may be
the use of preoperative data for the analysis of postoper-
ative increase of IL-6, resulting in the bias.
Conclusions
Our study showed that lower serum IL-6 level is found
after LAG treatment, compared with the IL-6 level
found after OG treatment, suggesting that LAG is a bet-
ter surgical procedure in treating GC patients, in light of
the adverse consequences of IL-6 mediated inflamma-
tion in GC patients. However, further studies with more
comprehensive data and larger sample-size are war-
ranted to strengthen our results.
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